Owner Angiochem Inc.

Inventors Regina, Anthony; Che, Christian; Beliveau, Richard; Demeule, Michel

Agent Pizzeys

Pub. Number AU-A-2008340943

PCT Pub. Number WO2009/079790

Priority 61/008,825 20.12.07 US

Filing date 19 December 2008

Wipo publication date 2 July 2009

C12N 15/00 (2006.01) Mutation or genetic engineering

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C12N 15/18 (2006.01) Mutation or genetic engineering

C12N 15/54 (2006.01) Mutation or genetic engineering - Transferases (2)

C12N 15/57 (2006.01) Mutation or genetic engineering - acting on peptide bonds (3.4)

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation